Radio Netics is a company that specializes in providing digital audio solutions, including internet radio, music streaming, and podcast services.

Radio Netics

Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company’s platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals. 

5AM Ventures

Frazier Healthcare Partners

GordonMD Global Investments

Crinetics Pharmaceuticals

DCVC Bio

Frazier Life Sciences

Radionetics Oncology

Radionetics Oncology announces participation in Goldman Sachs Healthruption: Third Anual Healthcare Disruption Conference

Connect with Paul Grayson or Brett Ewald for an in-person meeting at  #jpm2024 
www.radionetics.com


Welcome Paul Grayson! We are thrilled to have you in the team!
www.radionetics.com

We continue to push forward an exciting pipeline of first-in-class targets for #radiopharmaceuticals with the support of our partners Frazier Life Sciences, 5AM Ventures,Crinetics Pharmaceuticals, DCVC Bio, GordonMD® Global Investments LP 
www.radionetics.com 

Our warmest wishes for a happy holiday season and a very happy 2024

Metric
Company Name	Radio Netics
Symbol
MSH ID	COM:RADIONETICS
Market	PRIVATE
Sector	Consumer Services
Industry	Media and Entertainment
Country	US
Stage
Employee Count	25
Website	radionetics.com
LinkedIn	radionetics-oncology
Founders

Metric
Market Cap	148.79M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	18.96
28-Day Growth Score	23.51
90-Day Growth Score	20.19
365-Day Growth Score	53.81

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:RADIONETICS

Radio Netics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue